04.02.2010 • News

Ineos to Sell Fluorochemicals Business to Mexichem

Ineos Group has agreed terms for the sale of its fluorochemicals business to Mexichem Fluor, a subsidiary of Mexichem S.A. de C.V. The deal comprises the international business and assets related to Ineos' fluorochemical operations located in North America, Europe, and Asia. It is expected that on completion of the transaction, the business will become an integrated, global producer of speciality fluorochemicals with worldwide presence and annual sales revenue of over $500 million. Ineos Fluor CEO David Price said the fluorochemicals business no longer fits in with the company's group portfolio, which has been more and more focused on its large-scale petrochemicals businesses.

The sale is expected to be completed at the end of March, subject to necessary regulatory filings and approvals, including bank consent and approvals under applicable antitrust laws and regulations.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read